Glycosphingolipid synthesis in cerebellar purkinje neurons: Roles in myelin formation and axonal homeostasis

GLIA

Volumn 58, Issue 10, 2010, Pages 1197-1207

  Watanabe, Shun ^a,b,c   Endo, Shogo ^d   Oshima, Eriko ^a   Hoshi, Tomiko ^e,f   Higashi, Hideyoshi ^c   Yamada, Kazuyuki ^e   Tohyama, Koujiro ^f   Yamashita, Tadashi ^g   Hirabayashi, Yoshio ^a,b  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^e Brain Science Institute   (Japan)

^f IWATE MEDICAL UNIVERSITY   (Japan)

^g HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Glucosylceramide; Glycolipid; Glycosyltransferase; Myelination; Purkinje neuron

Indexed keywords

GLYCOSPHINGOLIPID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CREAM; DENDRITE; GENE DELETION; HOMEOSTASIS; IN VIVO STUDY; LIPOGENESIS; MEMBRANE STRUCTURE; MOUSE; MYELIN SHEATH; MYELINATION; NERVE FIBER; NERVE FIBER DEGENERATION; NERVE FIBER TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL;

AGING; ANIMALS; AXONAL TRANSPORT; AXONS; CELL MEMBRANE; CEREBELLUM; DENDRITES; GLUCOSYLTRANSFERASES; GLYCOSPHINGOLIPIDS; HOMEOSTASIS; MICE; MICE, KNOCKOUT; MYELIN SHEATH; NERVE DEGENERATION; NEURONS; PURKINJE CELLS;

EID: 77954356807     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20999     Document Type: Article

References (40)

1. Bartsch U, Montag D, Bartsch S, Schachner M. 1995. Multiply myelinated axons in the optic nerve of mice deficient for the myelin-associated glycoprotein. Glia 14:115-122.
2. Boldin S, Futerman AH. 1997. Glucosylceramide synthesis is required for basic fibroblast growth factor and laminin to stimulate axonal growth. J Neurochem 68:882-885. (Pubitemid 27044756)
3. Bosio A, Bussow H, Adam J, Stoffel W. 1998. Galactosphingolipids and axono-glial interaction in myelin of the central nervous system. Cell Tissue Res 292:199-210.
4. Bouslama-Oueghlani L, Wehrle R, Sotelo C, Dusart I. 2003. The developmental loss of the ability of Purkinje cells to regenerate their axons occurs in the absence of myelin: An in vitro model to prevent myelination. J Neurosci 23:8318-8329. (Pubitemid 37129649)
5. Chamberlain LH, Burgoyne RD, Gould GW. 2001. SNARE proteins are highly enriched in lipid rafts in PC12 cells: Implications for the spatial control of exocytosis. Proc Natl Acad Sci USA 98:5619-5624.
6. Coleman M. 2005. Axon degeneration mechanisms: Commonality amid diversity. Nat Rev Neurosci 6:889-898.
7. Dupree JL, Girault JA, Popko B. 1999. Axo-glial interactions regulate the localization of axonal paranodal proteins. J Cell Biol 147:1145-1152.
8. Freire E, Gomes FC, Jotha-Mattos T, Neto VM, Silva Filho FC, Coelho-Sampaio T. 2004. Sialic acid residues on astrocytes regulate neuritogenesis by controlling the assembly of laminin matrices. J Cell Sci 117(Part 18):4067-4076.
9. Fujii S, Igarashi K, Sasaki H, Furuse H, Ito K, Kaneko K, Kato H, Inokuchi J, Waki H, Ando S. 2002. Effects of the mono- and tetrasialogangliosides GM1 and GQ1b on ATP-induced long-term potentiation in hippocampal CA1 neurons. Glycobiology 12:339-344.
10. Furuya S, Irie F, Hashikawa T, Nakazawa K, Kozakai A, Hasegawa A, Sudo K, Hirabayashi Y. 1994. Ganglioside GD1 alpha in cerebellar Purkinje cells. Its specific absence in mouse mutants with Purkinje cell abnormality and altered immunoreactivity in response to conjunctive stimuli causing long-term desensitization. J Biol Chem 269:32418-32425.
11. Garcia-Fresco GP, Sousa AD, Pillai AM, Moy SS, Crawley JN, Tessarollo L, Dupree JL, Bhat MA. 2006. Disruption of axo-glial junctions causes cytoskeletal disorganization and degeneration of Purkinje neuron axons. Proc Natl Acad Sci USA 103:5137-5142.
12. Hering H, Lin CC, Sheng M. 2003. Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J Neurosci 23:3262-3271. (Pubitemid 36531967)
13. Hirano A, Dembitzer HM. 1967. A structural analysis of the myelin sheath in the central nervous system. J Cell Biol 34:555-567.
14. Hoshi T, Suzuki A, Hayashi S, Tohyama K, Hayashi A, Yamaguchi Y, Takeuchi K, Baba H. 2007. Nodal protrusions, increased Schmidt-Lanterman incisures, and paranodal disorganization are characteristic features of sulfatide-deficient peripheral nerves. Glia 55:584-594.
15. Ichikawa S, Hirabayashi Y. 1998. Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol 8:198-202.
16. Inoue M, Fujii Y, Furukawa K, Okada M, Okumura K, Hayakawa T, Furukawa K, Sugiura Y. 2002. Refractory skin injury in complex knock-out mice expressing only the GM3 ganglioside. J Biol Chem 277:29881-29888.
17. Ito H, Ishida H, Collins BE, Fromholt SE, Schnaar RL, Kiso M. 2003. Systematic synthesis and MAG-binding activity of novel sulfated GM1b analogues as mimics of Chol-1 (alpha-series) gangliosides: Highly active ligands for neural siglecs. Carbohydr Res 338:1621-1639.
18. Jennemann R, Sandhoff R, Wang S, Kiss E, Gretz N, Zuliani C, Martin-Villalba A, Jager R, Schorle H, Kenzelmann M, Bonrouhi M, Wiegandt H, Gröne HJ. 2005. Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth. Proc Natl Acad Sci USA 102:12459-12464.
19. Klopfenstein DR, Tomishige M, Stuurman N, Vale RD. 2002. Role of phosphatidylinositol(4,5)bisphosphate organization in membrane transport by the Unc104 kinesin motor. Cell 109:347-358.
20. Lazarov O, Morfini GA, Pigino G, Gadadhar A, Chen X, Robinson J, Ho H, Brady ST, Sisodia SS. 2007. Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1. J Neurosci 27:7011-7020.
21. Leclerc N, Schwarting GA, Herrup K, Hawkes R, Yamamoto M. 1992. Compartmentation in mammalian cerebellum: Zebrin II, P-path antibodies define three classes of sagittally organized bands of Purkinje cells. Proc Natl Acad Sci USA 89:5006-5010.
22. Maeda N, Niinobe M, Nakahira K, Mikoshiba K. 1988. Purification and characterization of P400 protein, a glycoprotein characteristic of Purkinje cell, from mouse cerebellum. J Neurochem 51:1724-1730.
23. Marks DL, Wu K, Paul P, Kamisaka Y, Watanabe R, Pagano RE. 1999. Oligomerization and topology of the Golgi membrane protein glucosylceramide synthase. J Biol Chem 274:451-456.
24. Marks N, Berg MJ, Saito M, Saito M. 2008. Glucosylceramide synthase decrease in frontal cortex of Alzheimer brain correlates with abnormal increase in endogenous ceramides: Consequences to morphology and viability on enzyme suppression in cultured primary neurons. Brain Res.
25. Mutoh T, Hirabayashi Y, Mihara T, Ueda M, Koga H, Ueda A, Kokura T, Yamamoto H. 2006. Role of glycosphingolipids and therapeutic perspectives on Alzheimer's disease. CNS Neurol Disord Drug Targets 5:375-380.
26. Mutoh T, Tokuda A, Inokuchi J, Kuriyama M. 1998. Glucosylceramide synthase inhibitor inhibits the action of nerve growth factor in PC12 cells. J Biol Chem 273:26001-26007.
27. Oberdick J, Smeyne RJ, Mann JR, Zackson S, Morgan JI. 1990. A promoter that drives transgene expression in cerebellar Purkinje and retinal bipolar neurons. Science 248:223-226. (Pubitemid 20146862)
28. Pigino G, Morfini G, Pelsman A, Mattson MP, Brady ST, Busciglio J. 2003. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J Neurosci 23:4499-4508. (Pubitemid 36706180)
29. Schafer DP, Bansal R, Hedstrom KL, Pfeiffer SE, Rasband MN. 2004. Does paranode formation and maintenance require partitioning of neurofascin 155 into lipid rafts? J Neurosci 24:3176-3185.
30. Schwarz A, Futerman AH. 1997. Distinct roles for ceramide and glucosylceramide at different stages of neuronal growth. J Neurosci 17:2929-2938. (Pubitemid 27175807)
31. Sheikh KA, Sun J, Liu Y, Kawai H, Crawford TO, Proia RL, Griffin JW, Schnaar RL. 1999. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci USA 96:7532-7537.
32. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, Goldstein LS. 2005. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307:1282-1288.
33. Sugiura Y, Furukawa K, Tajima O, Mii S, Honda T, Furukawa K. 2005. Sensory nerve-dominant nerve degeneration and remodeling in the mutant mice lacking complex gangliosides. Neuroscience 135:1167-1178.
34. Susuki K, Baba H, Tohyama K, Kanai K, Kuwabara S, Hirata K, Furukawa K, Furukawa K, Rasband MN, Yuki N. 2007. Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 55:746-757.
35. Vyas AA, Patel HV, Fromholt SE, Heffer-Lauc M, Vyas KA, Dang J, Schachner M, Schnaar RL. 2002. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci USA 99:8412-8417.
36. Yagashita S. 1979. Ultrastructural observations on axonal swelling in the human gracile nucleus. Virchows Arch A Pathol Anat Histol 382:217-226.
37. Yamashita T, Allende ML, Kalkofen DN, Werth N, Sandhoff K, Proia RL. 2005a. Conditional LoxP-flanked glucosylceramide synthase allele controlling glycosphingolipid synthesis. Genesis 43:175-180.
38. Yamashita T, Wada R, Sasaki T, Deng C, Bierfreund U, Sandhoff K, Proia RL. 1999. A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci USA 96:9142-9147.
39. Yamashita T, Wu YP, Sandhoff R, Werth N, Mizukami H, Ellis JM, Dupree JL, Geyer R, Sandhoff K, Proia RL. 2005b. Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc Natl Acad Sci USA 102:2725-2730.
40. Yang LJ, Zeller CB, Shaper NL, Kiso M, Hasegawa A, Shapiro RE, Schnaar RL. 1996. Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc Natl Acad Sci USA 93:814-818.